![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 08, 2017 7:19:22 PM
Sales for Mexico are down almost 90% (false and misleading)
Here is post #9438 in response to #9437:
You state that "Sales are down around 90% in Mexico (last quarter, another losing quarter they did a whopping 20k in sales!)"
Instead of just a snippit of information, lets take a look at the entire picture.
Sales (total revenue)
Annual (period ending)
6/30/16.....263k
6/30/15......86k
6/30/14.....529k
6/30/13.....153k
Quarterly (period ending)
3/31/17......21k
12/31/16....124k
9/30/16......36k
6/31/16......25k
3/31/16......77k
12/31/15.....70k
Looking closely at the data, one can see that yes, there was a large decline from the 12/31/16 quarter (124k) to the 3/31/17 quarter (21k). This is an 83% decline from the previous quarter. I presume this is supposed to be the 90% decline figure, but its not quite correct. Looking closer at the quarterly sales, one can see that the 124k is very large compared to the other quarterly sales, so the decline looks worse than it really is. Maybe a better measure is to average the 124k and the 21k? The average is 72.5k.
For fiscal year 2017, 2 quarters are reported with sales of 21k and 124k for a total of 145k. Assuming the same sales pace for the 2nd half of 2017, this would result in 290k sales for FY 2017.
Compare the 290k projection for 2017 with the previous 4 years:
2016 - 263k
2015 - 86k
2014 - 529k
2013 - 153k
The previous post would have you believe that sales are tanking when in fact they are holding pretty steady. The devil is in the details, so I encourage everyone to look closely at the details and to always consider the source of the posted information.
All data above is easily available on OTC Markets.
There are no LABS (false)
Labs to pill and package are contracted out.
There is no PHARMA (false)
Production, selling and marketing of drugs is pharma by definition.
So, if these 3 points are so easily debunked, then so the others are most likely bunk too.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM